Skip to content

Development of dietary therapy for elderly CKD patients with sarcopenia

Development of dietary therapy for elderly CKD patients with sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs051210079
Enrollment
20
Registered
2021-09-07
Start date
2023-12-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD, sarcopenia CKD, sarcopenia

Interventions

Two groups: normal-protein rice and low-protein rice.
protein restriction, low protein rice, exercise therapy

Sponsors

Kume Shinji
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women aged 65 years or older 2. Patients with CKD stage 3 or 4 (eGFR 15 to 59ml/min/1.73m2) 3. Patients who meet the diagnostic criteria for asia sarcopenia working group 2019 4. Patients who have given written consent

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to perform exercise therapy focusing on the lower body 2. Patients whose eGFR rate of decline exceeds -5 ml/min/1.73 m2/year 3. Patients who have dementia and have difficulty in implementing diet and exercise therapy 4. Patients on steroid therapy 5. Patients undergoing chemotherapy 6. Patients with dysphagia 7. Patients under 140 cm tall and over 170 cm tall 8. Patients with poor glycemic control (HbA1c 8.0% or more) 9. Patients with liver cirrhosis 10.Other patients deemed inappropriate for participation in this study.

Design outcomes

Primary

MeasureTime frame
Changes in body composition (muscle mass measured by DEXA method) and renal function (GFR measured by cystatin C) at the beginning of the dietary intervention and after 12 weeks

Secondary

MeasureTime frame
1 Changes in urinary protein (24 hour urine storage) at the beginning and after 12 weeks of dietary intervention 2 Changes in nutritional indices (serum albumin, prealbumin, total cholesterol, triglycerides, transferrin), physical functions (knee muscle strength, grip strength, normal walking speed, maximum walking speed), and protein intake (24 hour urine storage, estimated intake by dietary survey) between the start of the dietary intervention and 12 weeks later 3 Changes in the ratio of animal to vegetable protein intake (estimated intake by dietary survey) at the beginning of the dietary intervention and after 12 weeks. 4 Changes in body composition, renal function and proteinuria, and protein intake after 12 weeks of follow up after the end of the dietary intervention

Contacts

Public ContactShinji Kume

Shiga University of Medical Science

skume@belle.shiga-med.ac.jp+81-77-548-2267

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026